© 2026 NPR Illinois
For your right to be curious.
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Regeneron Pharmaceuticals To Test 'Antibody Cocktail' To Treat Coronavirus

NPR
Published May 13, 2020 at 12:11 PM CDT
A health worker takes a drop of blood for the COVID-19 antibody test after at the Diagnostic and Wellness Center on May 5, 2020, in Torrance, California. (Valerie Macon/AFP/Getty Images)
A health worker takes a drop of blood for the COVID-19 antibody test after at the Diagnostic and Wellness Center on May 5, 2020, in Torrance, California. (Valerie Macon/AFP/Getty Images)

People who recover from COVID-19 can develop antibodies to fight off coronavirus infections in the future. Several labs and pharmaceutical companies hope to harness the power of antibodies in a drug that could help treat and prevent COVID-19 in the general population.

Here & Now’s Tonya Mosley speaks with Leonard Schleifer, president and CEO of Regeneron Pharmaceuticals, a drug company that is preparing to test one such treatment in humans.

This article was originally published on WBUR.org.

Copyright 2021 NPR. To see more, visit https://www.npr.org.